INSUBCONTINENT EXCLUSIVE:
Drug firm Divi's Laboratories today reported a 0.89 per cent rise in its standalone net profit to Rs 261.60 crore for the fourth quarter
ended March 31.
The company had posted a net profit of Rs 259.29 crore for the corresponding period of the previous fiscal, Divi's
Laboratories said in a BSE filing.
Standalone total revenue from operations of the company stood at Rs 1,136.12 crore for the quarter under
It was Rs 1,087.57 crore for the same period a year ago.
For the fiscal year 2017-18, the company posted a standalone net profit of Rs
869.58 crore as against Rs 1,053.27 crore in the previous fiscal.
Standalone total revenue from operations stood at Rs 3,949.71 crore for
It was Rs 4,141.72 crore in the previous fiscal.
The company said its board has recommended a dividend of Rs 10 per share per equity share